Journal of Clinical Lipidology

metrics 2024

Elevating cardiovascular health through lipid research.

Introduction

Journal of Clinical Lipidology, published by Elsevier Science Inc, is a leading platform dedicated to advancing the understanding of lipidology and its impact on cardiovascular health. With an ISSN of 1933-2874 and E-ISSN 1876-4789, this esteemed journal boasts a remarkable Q1 ranking in key medical categories, including Cardiology and Cardiovascular Medicine, Internal Medicine, and Nutrition and Dietetics, solidifying its position as a vital resource for the latest research and clinical practices. This journal not only serves as a repository for groundbreaking studies but also provides insights into complex interactions between lipid metabolism and chronic diseases, including diabetes and obesity. Researchers, practitioners, and students will find a wealth of carefully vetted articles that drive innovation and improve patient outcomes in lipid management. Although it does not currently offer open access, the Journal of Clinical Lipidology ensures high visibility through rigorous peer review and a commitment to quality, making it an essential read for anyone invested in the future of lipidology.

Metrics 2024

SCIMAGO Journal Rank1.05
Journal Impact Factor3.60
Journal Impact Factor (5 years)3.80
H-Index73
Journal IF Without Self3.60
Eigen Factor0.01
Normal Eigen Factor1.14
Influence1.24
Immediacy Index1.30
Cited Half Life5.90
Citing Half Life6.80
JCI1.12
Total Documents1837
WOS Total Citations3960
SCIMAGO Total Citations14924
SCIMAGO SELF Citations1168
Scopus Journal Rank1.05
Cites / Document (2 Years)2.86
Cites / Document (3 Years)2.97
Cites / Document (4 Years)3.11

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #69/387
Percentile 82.17
Quartile Q1
Internal Medicine in Medicine
Rank #34/167
Percentile 79.64
Quartile Q1
Nutrition and Dietetics in Nursing
Rank #35/140
Percentile 75.00
Quartile Q2
Endocrinology, Diabetes and Metabolism in Medicine
Rank #67/244
Percentile 72.54
Quartile Q2

IF (Web Of Science)

PHARMACOLOGY & PHARMACY
Rank 94/354
Percentile 73.60
Quartile Q2

JCI (Web Of Science)

PHARMACOLOGY & PHARMACY
Rank 66/354
Percentile 81.36
Quartile Q1

Quartile History

Similar Journals

Clinica e Investigacion en Arteriosclerosis

Pioneering research that shapes the future of cardiology.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Nutrition and Metabolic Insights

Innovating dietary science for a healthier tomorrow.
Publisher: SAGE PUBLICATIONS LTDISSN: 1178-6388Frequency: 1 issue/year

Nutrition and Metabolic Insights is a distinguished open-access journal published by SAGE Publications Ltd, dedicated to advancing the fields of nutrition, metabolic processes, and dietary sciences. Since its inception in 2008, this journal has carved a niche for itself within the academic community, offering a platform for rigorous research and innovative findings. With a focus on multidisciplinary approaches, it publishes articles that explore vital aspects of Endocrinology, Diabetes and Metabolism, Food Science, and Nutrition and Dietetics, earning recognition with a 2023 Q2 ranking in Food Science and Q3 rankings in other critical categories. Researchers and professionals can access cutting-edge research that not only contributes to academic discourse but also informs clinical practice and public health discussions. By facilitating the dissemination of knowledge, Nutrition and Metabolic Insights plays a crucial role in improving health outcomes worldwide, making it an essential resource for students, researchers, and health professionals alike.

AMERICAN JOURNAL OF CLINICAL NUTRITION

Pioneering discoveries in nutrition and dietary practices.
Publisher: ELSEVIER SCIENCE INCISSN: 0002-9165Frequency: 12 issues/year

The American Journal of Clinical Nutrition, published by Elsevier Science Inc, stands as a premier academic platform dedicated to advancing knowledge in the fields of clinical nutrition and dietary science. With its roots tracing back to 1952, this prestigious journal boasts rigorous peer-reviewed research, providing vital insights and evidence-based findings that cater to the ever-evolving landscape of nutrition and health care. Affiliated with a strong reputation, the journal holds an impressive impact factor and is ranked in the top quartile (Q1) in both Nutrition and Dietetics and Medicine (miscellaneous), underscoring its significance in the academic community. With current Scopus rankings placing it #7 in Nursing and Nutrition and Dietetics and #20 in Medicine, it serves as an essential resource for researchers and practitioners seeking to stay at the forefront of clinical nutritional science. This journal not only disseminates groundbreaking research but also fosters collaborations among scholars, enhancing the clinical implications of nutrition practices globally. Access to the journal may vary, given its non-open access format; however, its contributions remain indispensable to professionals and students alike striving to deepen their understanding of clinical nutrition.

PROGRESS IN LIPID RESEARCH

Advancing the Frontiers of Lipid Science
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0163-7827Frequency: 4 issues/year

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.

PROSTAGLANDINS & OTHER LIPID MEDIATORS

Advancing the Frontiers of Lipid Research
Publisher: ELSEVIER SCIENCE INCISSN: 1098-8823Frequency: 6 issues/year

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

Molecular Metabolism

Catalyzing Knowledge in Cell and Molecular Biology
Publisher: ELSEVIERISSN: 2212-8778Frequency: 12 issues/year

Molecular Metabolism is a premier, open-access journal published by Elsevier, dedicated to advancing the understanding of metabolic processes at the molecular level. With an ISSN of 2212-8778 and a proud presence in Germany, the journal has made significant contributions to the fields of Cell Biology and Molecular Biology, consistently achieving a Q1 ranking in both categories as of 2023. The journal’s scope encompasses cutting-edge research that explores metabolic pathways, their regulation, and implications for human health, underscoring the interplay between metabolism and various biological functions. Researchers and professionals benefit from the journal’s robust visibility, as it ranks #40 among 410 journals in Molecular Biology and #35 among 285 in Cell Biology according to Scopus metrics, placing it in the top 10 percentile in its field. With open access since 2012, Molecular Metabolism ensures that groundbreaking research is available to all, fostering a collaborative and inclusive academic environment. Its commitment to excellence and accessibility makes it an invaluable resource for those invested in metabolic research.

Current Vascular Pharmacology

Advancing Knowledge in Vascular Health and Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1611Frequency: 6 issues/year

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

CURRENT OPINION IN LIPIDOLOGY

Exploring the forefront of lipid science.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0957-9672Frequency: 6 issues/year

Current Opinion in Lipidology is a premier journal published by Lippincott Williams & Wilkins, offering critical insights into the ever-evolving landscape of lipid research. With an impressive convergence spanning from 1990 to 2024, this journal serves as an essential platform for researchers, clinicians, and professionals dedicated to the study of lipids in relation to cardiovascular health, endocrinology, and metabolism. The journal currently holds a distinguished Q1 ranking in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics, showcasing its significant impact in these fields. Additionally, it ranks in the Q2 quartile for Cell Biology and Molecular Biology, underlining its comprehensive approach to lipidology. Though not open access, the content is rich with cutting-edge reviews, clinical studies, and expert opinions that aim to advance knowledge and practice in lipid metabolism, making it a valuable resource for anyone seeking to stay abreast of the latest developments in lipid research.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Catalyzing Innovations in Membrane Studies
Publisher: ELSEVIERISSN: 0005-2736Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES is a prestigious journal dedicated to advancing the field of biomembrane research, published by Elsevier. With a notable track record since its inception in 1967, this journal operates under the dual ISSN 0005-2736 and E-ISSN 1879-2642, and has firmly established itself within the scientific community by ranking in the top tiers of various disciplines, including Q2 in Biochemistry and Cell Biology, and Q1 in Biophysics as of 2023. Its impressive Scopus rankings further underscore its importance, with a rank of 24 in Biophysics reflecting its strong impact on ongoing research. Although it does not offer open access, the journal provides comprehensive insights and breakthroughs essential for scientists, researchers, and advanced students focused on biophysical and biochemical aspects of membranes. By disseminating pivotal findings, BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES contributes significantly to understanding cellular mechanisms, thereby serving as a vital resource for professionals aiming to explore the complexities of biological membranes.

Metabolic Syndrome and Related Disorders

Exploring the Interconnections of Metabolic Health
Publisher: MARY ANN LIEBERT, INCISSN: 1540-4196Frequency: 10 issues/year

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.